Betulinic Acid Inhibits Endometriosis Through Suppression of Estrogen Receptor β Signaling Pathway
Betulinic acid suppresses estrogen receptor β expression and signaling pathways, thereby inhibiting endometriotic cell proliferation and offering a potential therapeutic strategy for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The study investigated whether betulinic acid (BA) affects estrogen receptor β (ERβ) signaling in endometriotic cells and assessed downstream effects on inflammation, oxidative stress, mitochondrial function, and cell proliferation. Using human endometrial epithelial cells and an immortalized primary endometriotic epithelial line, the authors found ERβ was increased in endometriotic cells, while BA suppressed ERβ (not ERα) by inducing epigenetic changes at the ERβ promoter and reduced ERβ target genes including SOD2, NRF1, COX2, and MMP1, leading to increased oxidative stress, mitochondrial dysfunction, decreased proinflammatory cytokines, and reduced proliferation, paralleling ERβ knockdown. They further showed that lentiviral ERβ overexpression increased proliferation and proinflammatory cytokine release in normal endometrial cells, while BA diminished these effects by suppressing ERβ. This paper is centrally about endometriosis — BA is proposed to inhibit endometriosis by suppressing ERβ signaling and its inflammatory/oxidative downstream pathways.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Cyclooxygenase-2 in Endometriosis via openalex
- Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Estrogen Receptor (ER) β Regulates ERα Expression in Stromal Cells Derived from Ovarian Endometriosis via openalex
- Estrogen receptor β and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis via openalex
- Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis via openalex
- Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis via openalex
- Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions via openalex
- Genomic Function of Estrogen Receptor β in Endometriosis via openalex
- Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis via openalex
- Reversal of fortune: estrogen receptor-β in endometriosis via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- The Origin and Pathogenesis of Endometriosis via openalex
- W2108482850 via openalex
- W2128753121 via openalex
- W2151895436 via openalex
- W2158026627 via openalex
- W2024743405 via openalex
- W2344687780 via openalex
- W2400239628 via openalex
- W2476181555 via openalex
- W2492671947 via openalex
- W2544839468 via openalex
- W2749728500 via openalex
- W2765454168 via openalex
- W1970483536 via openalex
- W2902522405 via openalex
- W2014023055 via openalex
- W2958800522 via openalex
- W2969894012 via openalex
- W2007678546 via openalex
- W2986140453 via openalex
- W3002156037 via openalex
- W2000481853 via openalex
- W2056181147 via openalex
- W1977613766 via openalex
- W2046082610 via openalex
- W2060366874 via openalex
- W2077409457 via openalex
- W2100204252 via openalex
Cited by (10)
- Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review 2025
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- Mitochondrial Involvement in the Pathogenesis of Endometriosis and its Potential as Therapeutic Targets 2025
- EZH2 promotes endometriosis progression through estrogen receptor and TNFα expression 2025
- Endometriosis – hormones and treatment 2024
- Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway 2024
- Synergistic inhibitory effects of tetramethylpyrazine and evodiamine on endometriosis development 2024
- A comprehensive overview of exosome lncRNAs: emerging biomarkers and potential therapeutics in endometriosis 2023
- Identification of Potential Differentially Methylated Gene-Related Biomarkers in Endometriosis 2022
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:30.380497+00:00